n(1)-methylnicotinamide has been researched along with Ovarian Neoplasms in 1 studies
N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kilgour, MK | 1 |
MacPherson, S | 1 |
Zacharias, LG | 1 |
Ellis, AE | 1 |
Sheldon, RD | 1 |
Liu, EY | 1 |
Keyes, S | 1 |
Pauly, B | 1 |
Carleton, G | 1 |
Allard, B | 1 |
Smazynski, J | 1 |
Williams, KS | 1 |
Watson, PH | 1 |
Stagg, J | 1 |
Nelson, BH | 1 |
DeBerardinis, RJ | 1 |
Jones, RG | 1 |
Hamilton, PT | 1 |
Lum, JJ | 1 |
1 other study available for n(1)-methylnicotinamide and Ovarian Neoplasms
Article | Year |
---|---|
1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancer.
Topics: Ascites; Female; Humans; Niacinamide; Ovarian Neoplasms; Tumor Microenvironment | 2021 |